Target intelligence / Profile preview

Multiple antigens and Fc receptors

Molecular classification
Receptor, Antigen, Immunoglobulin-binding protein
01

Overview

Multiple antigens and Fc receptors refers to the collective set of molecular entities targeted by intravenous immunoglobulin (IVIG) and other polyclonal antibody preparations (DrugBank DB00073). The multiple antigens component represents the diverse array of pathogens, toxins, and autoantigens recognized by the variable regions (Fab) of the pooled antibodies, providing broad-spectrum neutralization and opsonization (StatPearls, IVIG). The Fc receptors component includes the family of cell surface proteins, such as FcγRI (CD64), FcγRII (CD32), and FcγRIII (CD16), as well as the neonatal Fc receptor (FcRn), which bind the constant region (Fc) of the antibodies (UniProt). These interactions mediate critical immunomodulatory effects, including the blockade of activating receptors on macrophages, the induction of inhibitory signaling through FcγRIIB, and the regulation of IgG half-life via FcRn saturation. This multi-faceted targeting is essential for the treatment of primary immunodeficiencies and various autoimmune and inflammatory conditions, such as immune thrombocytopenic purpura (ITP) and chronic inflammatory demyelinating polyneuropathy (CIDP).

Other names
IVIG targetsImmune globulin targetsPolyclonal immunoglobulin targetsFc gamma receptors and diverse antigens
02

Mechanism of action

The mechanism involves the neutralization of pathogens and toxins by Fab regions and the modulation of immune responses via Fc region binding to Fc receptors (FcγRs) and the neonatal Fc receptor (FcRn). This includes blocking activating Fc receptors on macrophages to prevent cell destruction, inducing inhibitory signaling through FcγRIIB, and accelerating the clearance of pathogenic autoantibodies by saturating FcRn.

03

Biological functions

Immune responseInflammationPhagocytosisComplement activationPassive immunity
04

Disease associations

Primary immunodeficiencyChronic inflammatory demyelinating polyneuropathyImmune thrombocytopenic purpuraKawasaki diseaseGuillain-Barre syndromeMultifocal motor neuropathy
05

Safety considerations

Infusion-related reactionsAcute renal failureThromboembolic eventsAseptic meningitisHemolytic anemia
06

Interacting drugs

Intravenous immunoglobulin

5 more in the full profile.

07

Biomarkers

Serum IgG levelsPlatelet countC-reactive protein (CRP)Erythrocyte sedimentation rate (ESR)

Beyond the preview

Go deeper on Multiple antigens and Fc receptors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple antigens and Fc receptors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call